AstraZeneca combo diabetes drug Qtrilmet approved in Europe.
The other drugs that received negotiated prices are Merck's diabetes drug Januvia, Novo Nordisk's diabetes drug Fiasp and NovoLog, AstraZeneca's
drug for Type 2 diabetes treatment, enhancing glycaemic control in diabetic patients. In October 2024, AstraZeneca India launched a Clinical Data and
Drug patents that are expiring from 2024 to 2024 ; Diabetes, Dapagliflozin Farxiga, Forxiga, AstraZeneca ; Diabetes, Sitagliptin Januvia, Merck Co.
UK-based drug company AstraZeneca focuses on drugs that treat Type 2 diabetes, cancer and respiratory issues.
CDSCO approves AstraZeneca's anti-diabetic drug Dapagliflozin with additional indications AstraZeneca India has received the Central Drugs
AstraZeneca Plc's (AZN.L) diabetes drug significantly reduced blood sugar levels in adolescents aged 10–17 with type 2 diabetes in a
Aurobindo, Glenmark each get U.S. FDA nod for copy of AstraZeneca's diabetes drug An error has occurred.
Januvia, a diabetes drug from Merck: $113.00, a 79% discount. Farxiga, AstraZeneca's diabetes drug: $178.50, a 68% discount. Entresto, a
Comments